Exabis Library
Welcome to the e-CCO Library!
OP04 Long-term outcomes after ileocolonic resection in Crohn’s disease according to the severity of early endoscopic recurrence
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP04: Efficacy of upadacitinib in ulcerative colitis: A phase 3 post hoc analysis of biologic- and anti-TNF-inadequate response patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP04: Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP04: Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP05 Validation of the Lémann index in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP05: Association of ultra-processed food intake with risk of Inflammatory Bowel Disease from the prospective urban rural epidemiology (PURE) study: A prospective cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP05: Crohn’s disease exclusion diet is equally effective but better tolerated than exclusive enteral nutrition for induction of remission in mild-to-moderate active paediatric Crohn’s disease: a prospective randomised controlled trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP05: High-dimensional single-cell analysis identifies cellular signatures associated with response to vedolizumab therapy in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP05: Outcome of induction therapy with vedolizumab in children: Results from the prospective, multi-centre VEDOKIDS study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP06: 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP06: Multiomic interrogation of the epithelium in active Ulcerative Colitis reveals dysregulated myeloid cells associated with non-response to anti-Tumour Necrosis Factor therapy.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP06: The influence of different prednisolone tapering algorithms on the effectiveness of infliximab in patients with Ulcerative Colitis – A real-world cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP07 The epidemiology of inflammatory bowel diseases among immigrants to Denmark: A population-based cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP07: Absolute and relative risks of kidney and urological complications in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP07: Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP07: Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM